Spinal cord ependymomas in children and adolescents

Martin Benesch, Didier Frappaz, Maura Massimino

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background Spinal cord ependymomas are very rare among children and adolescents. Due to their rarity, our current knowledge of these tumors is based on case reports and few retrospective case series. Methods The present review summarizes the currently available literature on childhood spinal cord ependymomas. Results Although overall survival rates are favorable, relapse incidence is high, particularly in myxopapillary ependymomas. Since long-term follow-up data are provided in a limited number of studies only, the true relapse incidence is unknown. Maximal safe radical surgery is the backbone of treatment for children with spinal cord ependymomas, but the impact of adjuvant treatment on progression and survival is still unclear. Presently, the decision to initiate nonsurgical treatment depends primarily on the WHO grade of the tumor and the extent of resection. In terms of the known side effects, early radiotherapy should be avoided in children with WHO grade II spinal cord ependymomas irrespective of the extent of resection but is indicated in anaplastic spinal cord ependymomas both after complete and incomplete resection. The high relapse incidence in myxopapillary ependymomas argue for the use of early radiotherapy, but its definitive impact on progression has to be proven in larger series. Close surveillance is important due to the high recurrence rate in all patients with spinal cord ependymomas. Conclusion Prospective collection of both clinical and molecular data from a greater number of patients with spinal cord ependymomas within an international collaboration is the prerequisite to establish standardized management guidelines for these rare CNS tumors.

Original languageEnglish
Pages (from-to)2017-2028
Number of pages12
JournalChild's Nervous System
Volume28
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Ependymoma
Spinal Cord
Recurrence
Incidence
Radiotherapy
Neoplasms
Therapeutics
Survival Rate
Guidelines
Survival

Keywords

  • Adolescents
  • Children
  • Ependymomas
  • Spinal cord

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Spinal cord ependymomas in children and adolescents. / Benesch, Martin; Frappaz, Didier; Massimino, Maura.

In: Child's Nervous System, Vol. 28, No. 12, 12.2012, p. 2017-2028.

Research output: Contribution to journalArticle

Benesch, Martin ; Frappaz, Didier ; Massimino, Maura. / Spinal cord ependymomas in children and adolescents. In: Child's Nervous System. 2012 ; Vol. 28, No. 12. pp. 2017-2028.
@article{8f3e9afececb4eeea60242e6764ebb50,
title = "Spinal cord ependymomas in children and adolescents",
abstract = "Background Spinal cord ependymomas are very rare among children and adolescents. Due to their rarity, our current knowledge of these tumors is based on case reports and few retrospective case series. Methods The present review summarizes the currently available literature on childhood spinal cord ependymomas. Results Although overall survival rates are favorable, relapse incidence is high, particularly in myxopapillary ependymomas. Since long-term follow-up data are provided in a limited number of studies only, the true relapse incidence is unknown. Maximal safe radical surgery is the backbone of treatment for children with spinal cord ependymomas, but the impact of adjuvant treatment on progression and survival is still unclear. Presently, the decision to initiate nonsurgical treatment depends primarily on the WHO grade of the tumor and the extent of resection. In terms of the known side effects, early radiotherapy should be avoided in children with WHO grade II spinal cord ependymomas irrespective of the extent of resection but is indicated in anaplastic spinal cord ependymomas both after complete and incomplete resection. The high relapse incidence in myxopapillary ependymomas argue for the use of early radiotherapy, but its definitive impact on progression has to be proven in larger series. Close surveillance is important due to the high recurrence rate in all patients with spinal cord ependymomas. Conclusion Prospective collection of both clinical and molecular data from a greater number of patients with spinal cord ependymomas within an international collaboration is the prerequisite to establish standardized management guidelines for these rare CNS tumors.",
keywords = "Adolescents, Children, Ependymomas, Spinal cord",
author = "Martin Benesch and Didier Frappaz and Maura Massimino",
year = "2012",
month = "12",
doi = "10.1007/s00381-012-1908-4",
language = "English",
volume = "28",
pages = "2017--2028",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Spinal cord ependymomas in children and adolescents

AU - Benesch, Martin

AU - Frappaz, Didier

AU - Massimino, Maura

PY - 2012/12

Y1 - 2012/12

N2 - Background Spinal cord ependymomas are very rare among children and adolescents. Due to their rarity, our current knowledge of these tumors is based on case reports and few retrospective case series. Methods The present review summarizes the currently available literature on childhood spinal cord ependymomas. Results Although overall survival rates are favorable, relapse incidence is high, particularly in myxopapillary ependymomas. Since long-term follow-up data are provided in a limited number of studies only, the true relapse incidence is unknown. Maximal safe radical surgery is the backbone of treatment for children with spinal cord ependymomas, but the impact of adjuvant treatment on progression and survival is still unclear. Presently, the decision to initiate nonsurgical treatment depends primarily on the WHO grade of the tumor and the extent of resection. In terms of the known side effects, early radiotherapy should be avoided in children with WHO grade II spinal cord ependymomas irrespective of the extent of resection but is indicated in anaplastic spinal cord ependymomas both after complete and incomplete resection. The high relapse incidence in myxopapillary ependymomas argue for the use of early radiotherapy, but its definitive impact on progression has to be proven in larger series. Close surveillance is important due to the high recurrence rate in all patients with spinal cord ependymomas. Conclusion Prospective collection of both clinical and molecular data from a greater number of patients with spinal cord ependymomas within an international collaboration is the prerequisite to establish standardized management guidelines for these rare CNS tumors.

AB - Background Spinal cord ependymomas are very rare among children and adolescents. Due to their rarity, our current knowledge of these tumors is based on case reports and few retrospective case series. Methods The present review summarizes the currently available literature on childhood spinal cord ependymomas. Results Although overall survival rates are favorable, relapse incidence is high, particularly in myxopapillary ependymomas. Since long-term follow-up data are provided in a limited number of studies only, the true relapse incidence is unknown. Maximal safe radical surgery is the backbone of treatment for children with spinal cord ependymomas, but the impact of adjuvant treatment on progression and survival is still unclear. Presently, the decision to initiate nonsurgical treatment depends primarily on the WHO grade of the tumor and the extent of resection. In terms of the known side effects, early radiotherapy should be avoided in children with WHO grade II spinal cord ependymomas irrespective of the extent of resection but is indicated in anaplastic spinal cord ependymomas both after complete and incomplete resection. The high relapse incidence in myxopapillary ependymomas argue for the use of early radiotherapy, but its definitive impact on progression has to be proven in larger series. Close surveillance is important due to the high recurrence rate in all patients with spinal cord ependymomas. Conclusion Prospective collection of both clinical and molecular data from a greater number of patients with spinal cord ependymomas within an international collaboration is the prerequisite to establish standardized management guidelines for these rare CNS tumors.

KW - Adolescents

KW - Children

KW - Ependymomas

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=84871213903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871213903&partnerID=8YFLogxK

U2 - 10.1007/s00381-012-1908-4

DO - 10.1007/s00381-012-1908-4

M3 - Article

C2 - 22961356

AN - SCOPUS:84871213903

VL - 28

SP - 2017

EP - 2028

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 12

ER -